Evidence mapPaperPMID 35041662Full record

Trial reportPLoS medicine2022

Effects of preconception lifestyle intervention in infertile women with obesity: The FIT-PLESE randomized controlled trial.

Richard S Legro, Karl R Hansen, Michael P Diamond, Anne Z Steiner, Christos Coutifaris, Marcelle I Cedars, Kathleen M Hoeger, Rebecca Usadi, Erica B Johnstone, Daniel J Haisenleder and 12 more

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PLoS medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 50 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 5 pooled it
18.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06975111 phase2 / phase3recruitingstarted 2026, after this paper: background citation

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Ran2026Enrolled200Registered outcomes10Posted comparisons0ConditionsCardiovascular, Menopause, Menopause Hot Flashes, Menopause Related ConditionsArmsAnti-hypertensives, Fezolinetant, Hormonal therapy, Life Style Intervention, Lipid Lowering Medication
Open the trial in the graph
NCT02432209 phase3completednot on this map

Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained Infertility

TypeinterventionalSponsorYale UniversityRan2015 to 2020Enrolled379ConditionsInfertility, FemaleArmsCaloric Restriction, Orlistat, Moderate physical activity
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 5 syntheses or guidelines pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Weight management in women of reproductive age.Obesity and endocrinology · 2026
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 17 institutions in 1 country.

Richard S LegroDepartment of Obstetrics and Gynecology, Penn State College of Medicine, Hershey, Pennsylvania, United States of America.ORCID 0000-0001-9927-7584
Karl R HansenDepartment of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.ORCID 0000-0002-2122-8843
Michael P DiamondDepartment of Obstetrics and Gynecology, Augusta University, Augusta, Georgia, United States of America.ORCID 0000-0001-6353-4489
Anne Z SteinerDepartment of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina, United States of America.ORCID 0000-0002-4203-3754
Christos CoutifarisDepartment of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Marcelle I CedarsDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of California at San Francisco, San Francisco, California, United States of America.
Kathleen M HoegerDepartment of Obstetrics and Gynecology, University of Rochester, Rochester, New York, United States of America.ORCID 0000-0001-9285-3606
Rebecca UsadiDepartment of Obstetrics and Gynecology, Atrium Health, Charlotte, North Carolina, United States of America.ORCID 0000-0003-3553-4734
Erica B JohnstoneDepartment of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah, United States of America.ORCID 0000-0002-3382-3500
Daniel J HaisenlederLigand Core Laboratory, University of Virginia Center for Research in Reproduction, Charlottesville, Virginia, United States of America.
Robert A WildDepartment of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
Kurt T BarnhartDepartment of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Jennifer MersereauDepartment of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina, United States of America.
J C TrussellDepartment of Urology, SUNY Upstate University Hospital, Syracuse, New York, United States of America.ORCID 0000-0002-4784-7896
Stephen A KrawetzDepartment of Obstetrics and Gynecology and Center for Molecular Medicine and Genetics, Wayne State University, Detroit, Michigan, United States of America.ORCID 0000-0002-7113-2364
Penny M Kris-EthertonDepartment of Nutritional Sciences, Penn State College of Health and Human Development, Pennsylvania, United States of America.
David B SarwerCenter for Obesity Research and Education, College of Public Health, Temple University, Philadelphia, Pennsylvania, United States of America.
Nanette SantoroDepartment of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.ORCID 0000-0001-9096-7490
Esther EisenbergFertility and Infertility Branch, NICHD, Rockville, Maryland, United States of America.ORCID 0000-0003-3033-6384
Hao HuangDepartment of Biostatistics, Yale University, New Haven, Connecticut, United States of America.
Heping ZhangDepartment of Biostatistics, Yale University, New Haven, Connecticut, United States of America.ORCID 0000-0002-0688-4076
Reproductive Medicine Network
University of North Carolina at Chapel Hill · USUniversity of Oklahoma Health Sciences Center · USUniversity of Pennsylvania · USYale University · USAtrium Medical Cente · USAugusta University · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USPenn State Milton S. Hershey Medical Center · USPennsylvania State University · USSUNY Upstate Medical University · USTemple University · USUniversity of California, San Francisco · USUniversity of Colorado Denver · USUniversity of Rochester · USUniversity of Utah · USUniversity of Virginia · USWayne State University · US

Funding

Yale Clinical and Translational Science AwardUL1TR001863 · YALE UNIVERSITY · 2025 to 2025
$9.9M
PROGESTERONE/ANDROGEN FEEDBACK CONTROL OF GNRH NEURONSU54HD028934 · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · 1998 to 2005
$6.8M
Penn State Clinical and Translational Science InstituteUL1TR002014 · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · 2025 to 2025
$3.8M
COOPERATIVE MULTICENTER REPRODUCTIVE MEDICINE NETWORKU10HD039005 · WAYNE STATE UNIVERSITY · 2000 to 2004
$1.4M
COOPERATIVE MULTICENTER REPRODUCTIVE MEDICINE NETWORKU10HD027049 · UNIVERSITY OF PENNSYLVANIA · 1990 to 2004
$1.2M
COOPERATIVE MULTICENTER REPRODUCTIVE MEDICINE NETWORKU10HD038992 · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · 2000 to 2004
$1.2M
MIGRATION AND URBAN FERTILITYR01HD029834 · YALE UNIVERSITY · 1995 to 1997
NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR002014NICHD NIH HHS R01 HD029834NICHD NIH HHS R03 HD101893NICHD NIH HHS R24 HD102061NICHD NIH HHS U10 HD027049NICHD NIH HHS U10 HD038992NICHD NIH HHS U10 HD039005NICHD NIH HHS U10 HD055925NICHD NIH HHS U10 HD077680NICHD NIH HHS U10 HD077844NICHD NIH HHS U54 HD028934
6 · The paper itself

Abstract

backgroundWomen with obesity and infertility are counseled to lose weight prior to conception and infertility treatment to improve pregnancy rates and birth outcomes, although confirmatory evidence from randomized trials is lacking. We assessed whether a preconception intensive lifestyle intervention with acute weight loss is superior to a weight neutral intervention at achieving a healthy live birth. METHODS AND

findingsIn this open-label, randomized controlled study (FIT-PLESE), 379 women with obesity (BMI ≥ 30 kg/m2) and unexplained infertility were randomly assigned in a 1:1 ratio to 2 preconception lifestyle modification groups lasting 16 weeks, between July 2015 and July 2018 (final follow-up September 2019) followed by infertility therapy. The primary outcome was the healthy live birth (term infant of normal weight without major anomalies) incidence. This was conducted at 9 academic health centers across the United States. The intensive group underwent increased physical activity and weight loss (target 7%) through meal replacements and medication (Orlistat) compared to a standard group with increased physical activity alone without weight loss. This was followed by standardized empiric infertility treatment consisting of 3 cycles of ovarian stimulation/intrauterine insemination. Outcomes of any resulting pregnancy were tracked. Among 191 women randomized to standard lifestyle group, 40 dropped out of the study before conception; among 188 women randomized to intensive lifestyle group, 31 dropped out of the study before conception. All the randomized women were included in the intent-to-treat analysis for primary outcome of a healthy live birth. There were no significant differences in the incidence of healthy live births [standard 29/191(15.2%), intensive 23/188(12.2%), rate ratio 0.81 (0.48 to 1.34), P = 0.40]. Intensive had significant weight loss compared to standard (-6.6 ± 5.4% versus -0.3 ± 3.2%, P < 0.001). There were improvements in metabolic health, including a marked decrease in incidence of the metabolic syndrome (baseline to 16 weeks: standard: 53.6% to 49.4%, intensive 52.8% to 32.2%, P = 0.003). Gastrointestinal side effects were significantly more common in intensive. There was a higher, but nonsignificant, first trimester pregnancy loss in the intensive group (33.3% versus 23.7% in standard, 95% rate ratio 1.40, 95% confidence interval [CI]: 0.79 to 2.50). The main limitations of the study are the limited power of the study to detect rare complications and the design difficulty in finding an adequate time matched control intervention, as the standard exercise intervention may have potentially been helpful or harmful.

conclusionsA preconception intensive lifestyle intervention for weight loss did not improve fertility or birth outcomes compared to an exercise intervention without targeted weight loss. Improvement in metabolic health may not translate into improved female fecundity.

trial registrationClinicalTrials.gov NCT02432209.

Indexed as

Life StyleAdultExerciseFemaleFertilizationHumansInfertilityInfertility, FemalePreconception CareUnited StatesWeight LossYoung Adult

Identifiers

PMID35041662
PMCPMC8765626
OpenAlexW4206258831

What Socratic holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.